Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPX4 | P36969 | 2/20 | 0.71 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.59 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.47 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19041921 | 0.94 | GPX4 (0.76) | GPX4TXNRD1GPR52NLRP3PTPN1 | |
| SCHEMBL19036316 | 0.94 | GPX4 (0.76) | GPX4TXNRD1GPR52NLRP3PTPN1 | |
| SCHEMBL19036377 | 0.94 | GPX4 (0.62) | GPX4TXNRD1GPR52NLRP3PTPN1 | |
| SCHEMBL19041959 | 0.92 | GPX4 (0.68) | GPX4TXNRD1GPR52NLRP3PTPN1 | |
| SCHEMBL19036361 | 0.88 | GPX4 (0.67) | GPX4TXNRD1GPR52NLRP3PTPN1 | |
| SCHEMBL19041919 | 0.87 | GPX4 (0.64) | GPX4TXNRD1GPR52NLRP3PTPN1 | |
| SCHEMBL19036297 | 0.87 | GPX4 (0.64) | GPX4TXNRD1GPR52NLRP3PTPN1 | |
| SCHEMBL19036274 | 0.83 | GPX4 (0.66) | GPX4TXNRD1GPR52PTPN1PTPN2 | |
| SCHEMBL19041954 | 0.83 | TXNRD1 (0.69) | GPX4TXNRD1GPR52PTPN1PTPN2 | |
| SCHEMBL19041970 | 0.82 | GPX4 (0.76) | GPX4TXNRD1GPR52PTPN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170182001-A1 | NOVEL SESQUITERPENE DERIVATIVES AND THEIR USE IN INFLAMMATION OR CANCER TREATMENT | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170182001-A1 | NOVEL SESQUITERPENE DERIVATIVES AND THEIR USE IN INFLAMMATION OR CANCER TREATMENT | GSTK1, MIF, GSTA1 | GPX4 242/4885TXNRD1 312/4885GPR52 661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.